FINEOTEX CHEMICAL LTD. - 533333 - Disclosure Of Related Party Transactions For The Half Year Ended 30Th September, 2020.
Dear Sir/Madam, Pursuant to the provisions of Regulation 23(9) of the Securities and Exchange Board of India (Listing Obligation and Disclosure Requirements) Regulations, 2015 as amended, we enclosed herewith the disclosure of Related Party Transactions for the half year ended on 30th September, 2022. FINEOTEX CHEMICAL LTD. - 533333 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Transcript of Concall with Investors and Analyst held on 07th November, 2022.
FINEOTEX CHEMICAL LTD. - 533333 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Newspaper Advertisement of Unaudited Results for the Quarter and Half Year ended 30th September, 2022 FINEOTEX CHEMICAL LTD. - 533333 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Pursuant to Regulation 46(2)(oa) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform the exchanges that the recording of the Company''s Analyst Call held today on company''s financial performance for Q2 and H1 FY2023 is available on the website of the Company. Q2FY23 Quarterly Result Announced for Fineotex Chemical Ltd.
Fineotex Chemical announced Q2FY23 results: Consolidated result of H1FY23 vs H1FY22: The revenue from operation increased by 90.5%, i.e. to Rs 27,008 lakh from Rs 14,177 lakh The operational EBIDTA increased by 109%, i.e. to Rs 5,134 lakh from Rs 2,461 lakh The profit after tax (PAT) increased by 97.4%, i.e. to Rs 4,108 lakh from Rs 2,081 lakh The earnings per share (EPS) increased by 99.5%, i.e. to Rs 3.63 from Rs 1.82 per shar Consolidated result of Q2FY23 vs Q2FY22: The revenue from operation increased by 71%, i.e. to Rs 13,431 lakh from Rs 7,849 lakh The operational EBIDTA increased by 70%, i.e. to Rs 2,509 lakh from Rs 1,479 lakh PAT increased by 86.8%, i.e. to Rs 2,077 lakh from Rs 1,112 lakh EPS increased by 92%, i.e. to Rs 1.86 per share from Rs 0.97 per share Sanjay Tibrewala, Executive Director and CFO, Fineotex Chemical, said, “We are delighted to continue our consistent performance in delivering another successful quarter. Our revenue growth and EBIDTA growth figures of ~71 % and ~70%, respectively during the quarter, reflect the confidence on the quality of our products and services by our customers. Our strategic vision of expansion and product diversification during the lean periods of the pandemic has been successful. Our facility at Ambernath is a clear testimony to our vision to expand our capacity and product range, thus helping us strengthen our competitive position in the market. To cater to the strong demand momentum, we have ramped up our Ambernath plant capacity to 40,000 MTPA and will further extend the capacity by 21,000 MTPA. Despite the global economic downturn, our performance for the quarter has been significantly better. We are also pleased to announce that the notable credit rating agency, ICRA, rated our long-term debt as “ICRA A” and short-term debt as “ICRA A1”. Arindam Choudhuri, CEO, said, "Our expansion plans to offer value-added products and solutions are in sync with the interest of stakeholders. We have been catering to increase in demand from both existing and new customers—on quality, quantity, time and geography basis. A sense of trust is instilled in our customers for our ability to meet their demands. Going forward, we are confident of continuing to render services of similar quality. Regarding ESG and sustainability aspects, we are well-equipped to handle the same with a greater sense of responsibility. While focusing on environment protection, we already have all the best practices in place and thus ensure to keep the waste emission to a minimum and efficiently manage the release of dangerous chemicals.” Result PDF FINEOTEX CHEMICAL LTD. - 533333 - Regulation 30, Regulations, 2015, III Part A (15) Of SEBI (Listing Obligations & Disclosure Schedule Requirements).
Dear Sirs/Madam, With reference to the above caption subject, we enclose Earning Presentation for the quarter and half year ended 30th September, 2022 requesting you to kindly take this on your record. Kindly acknowledge receipt of the same. FINEOTEX CHEMICAL LTD. - 533333 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed a Press Release issued by the Company for the Earning Update of H1 and Q2 for the FY 2022-23. FINEOTEX CHEMICAL LTD. - 533333 - Intimation Pursuant To Regulation 30 And Other Applicable Regulations Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("Listing Regulations")
Intimation pursuant to Regulation 30 and other applicable regulations of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ("Listing Regulations"), Please be informed that the Nomination and Remuneration Committee of the Board of directors in their meeting held on November 4, 2022 has approved a further grant of 8,000 options to eligible employees of the Company (which includes the employees of its wholly owned subsidiary) at price of Rs. 2/- (Rupees Two) per option under the `Fineotex Chemical Limited-Employees Stock Option Plan 2020'' as amended ("FCL-ESOP 2020"). FINEOTEX CHEMICAL LTD. - 533333 - Outcome Of Board Meeting For Result Of 30Th September 2022
We wish to inform you that at the meeting of the Board of Directors held on 4th November, 2022 the board inter-alia, have approved and adopted Un-Audited Financial Results Standalone and Consolidated) of the Company and the Limited Review Reports (Standalone and Consolidated) for the Second Quarter and Half year ended on 30th September, 2022.